Biological variability in assessing the clinical value of biochemical markers of bone turnover

Citation
M. Plebani et al., Biological variability in assessing the clinical value of biochemical markers of bone turnover, CLIN CHIM A, 299(1-2), 2000, pp. 77-86
Citations number
26
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CLINICA CHIMICA ACTA
ISSN journal
00098981 → ACNP
Volume
299
Issue
1-2
Year of publication
2000
Pages
77 - 86
Database
ISI
SICI code
0009-8981(200009)299:1-2<77:BVIATC>2.0.ZU;2-M
Abstract
Analytical and biological variability of three bone markers, deoxypyridinol ine (DPD), Cross-Laps (CTx) and galactosylhydroxylysine (GHYL) were compare d. From 14 healthy subjects (six women, eight men; age 29-44 years) recruit ed from our laboratory staff, two sets of samples of early morning urine we re obtained - four samples taken weekly for 4 weeks (all subjects) and thre e samples taken monthly for 3 months from five subjects. Data were expresse d as the ratio to creatinine concentration. All the methods met the analyti cal goals (CVA less than or equal to 1/2CV(1within-subject)) DPD 0.06, CTx 0.05 and GHYL 0.07 with CV1within-subject being 0.22, 0.29 and 0.38, respec tively. The reference values were of limited usefulness particularly for CT x and GHYL, the index of individuality (II) being 0.50 and 0.48 respectivel y. As the index of heterogeneity (IH) was not significant, being 0.23 for C Tx, 0.28 for DPD and 0.46 for GHYL, which are all <1.71 (1 + 2S.D.), within -subject variances can be used to calculate the reference change value (RCV ): 0.58 for DPD, 0.54 for CTx and 1.08 for GHYL. Moreover, we found constan t variations in DPD and CTx, week to week and month to month. Our findings suggest that DPD and CTx provide more reliable results than GHYL, showing a lower within-subject variation, a lower and rime-constant RCV allowing rel iable monitoring without regard for timing. (C) 2000 Elsevier Science B.V. All rights reserved.